FindTrial
Sign In

Study on the Mechanism of TRAF6 in Regulating IL-4/STAT6 Signaling Pathway Activation in Macrophage M2 Polarization and Atherosclerosis

Study on the Mechanism of TRAF6 in Regulating IL-4/STAT6 Signaling Pathway Activation in Macrophage M2 Polarization and Atherosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115100
Enrollment
Unknown
Registered
2025-12-22
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Interventions

AS group:None
Healthy group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.AS patients who meet the diagnostic criteria for AS;

Exclusion criteria

Exclusion criteria: 1.Patients with other immune system disorders; 2.Patients with other immune system disorders; 3.Malignant tumors, hematological disorders, immune dysfunction and other diseases;

Design outcomes

Primary

MeasureTime frame
The protein expression and mRNA abundance of TRAF6;—

Countries

China

Contacts

Public ContactJiashan Li

Huzhou Center Hospital

jiashan_0620@sina.com+86 572 220 1234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026